APA (7th ed.) Citation

Wonisch, W., Tatzber, F., Lindschinger, M., Falk, A., Resch, U., Mörkl, S., . . . Cvirn, G. Overview of Clinical Relevance of Antibodies Against Oxidized Low-Density Lipoprotein (oLAb) Within Three Decades by ELISA Technology. MDPI AG.

Chicago Style (17th ed.) Citation

Wonisch, Willibald, Franz Tatzber, Meinrad Lindschinger, Andreas Falk, Ulrike Resch, Sabrina Mörkl, Neven Zarkovic, and Gerhard Cvirn. Overview of Clinical Relevance of Antibodies Against Oxidized Low-Density Lipoprotein (oLAb) Within Three Decades by ELISA Technology. MDPI AG.

MLA (9th ed.) Citation

Wonisch, Willibald, et al. Overview of Clinical Relevance of Antibodies Against Oxidized Low-Density Lipoprotein (oLAb) Within Three Decades by ELISA Technology. MDPI AG.